Great Basin Scientific

Robbins Arroyo LLP Is Investigating the Officers and Directors of Great Basin Scientific, Inc. (GBSN) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of Great Basin Scientific, Inc. (NASDAQCM: GBSN) violated federal securities laws by issuing materially misleading business information to the investing public. Great Basin Scientific, a molecular diagnostic testing company, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic systems that are designed to test hospital-acquired infections.

Great Basin Scientific Shares Suffer Massive Dilution

On February 25, 2015, Great Basin Scientific offered 2,724,000 units for sale in a public offering. However, because these units could be converted into preferred stock and warrants it obligated the company to issue hundreds of millions of new Great Basin shares. This resulted in massive dilution causing damage to shareholders.

Great Basin Scientific Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.


Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Phone *
E-mail * Confirm: E-mail *
Number of Shares Owned:

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information

    Send This Post